Demo Sign up Log In

Antares Pharma, Inc. (ATRS)

Operating Expenses

$112.69M

TTM · Period ending: Mar 31, 2022 · USD

ATRS Operating Expenses

Latest reported$112.69Mperiod endingMar 31, 2022

Latest reported$112.69Mperiod endingMar 31, 2022

ATRS Operating Expenses ($5.00M → $112.69M)

Annual operating expenses

High-resolution chart · PNG

ATRS operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Operating Expenses — Annual fiscal periods (USD)
Period ending	Operating Expenses (USD)
Dec 31, 2021	156,640,000
Dec 31, 2020	72,880,000
Dec 31, 2019	72,397,000
Dec 31, 2018	49,090,000
Dec 31, 2017	43,500,000
Dec 31, 2016	47,521,740
Dec 31, 2015	46,662,396
Dec 31, 2014	50,378,265
Dec 31, 2013	32,271,587
Dec 31, 2012	24,506,605
Dec 31, 2011	14,098,087
Dec 31, 2010	14,571,946
Dec 31, 2009	13,864,872
Dec 31, 2008	15,839,095
Dec 31, 2007	13,060,562
Dec 31, 2006	10,989,258
Dec 31, 2005	9,677,175
Dec 31, 2004	9,748,320
Dec 31, 2003	10,413,000
Dec 31, 2002	11,684,377
Dec 31, 2001	10,258,108
Dec 31, 2000	5,218,558
Dec 31, 1999	5,307,372
Dec 31, 1998	6,944,673
Dec 31, 1997	5,935,894
Dec 31, 1996	5,001,221

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.